Effects of high-dose phytoestrogens on circulating cellular microparticles and coagulation function in postmenopausal women

Journal of the Formosan Medical Association

Volumn 114, Issue 8, 2015, Pages 710-716

  Cheng, Wern Cherng ^a   Lo, Shyi Chyi ^a   Tsai, Keh Sung ^a   Tu, Shih Te ^b   Wu, Jin Shan ^c   Chang, Ching I ^d   Chen, Chi Ling ^e   Shaw, Ning Sing ^e   Peng, Hui Yu ^f   Wang, Shu Yi ^b   Wu, Chih Hsing ^c   Jan, I Shaw ^a   Hsu, Ssu Chun ^a   Liu, Chao Wei ^a   Lee, Li Na ^a   Tai, Tong Yuan ^d,g  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g Taipei Jen Chi Relief Institute   (Taiwan)

Author keywords

Coagulation factors; Isoflavones; Microparticles; Phytoestrogens; Postmenopausal women

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIGEN; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 7; D DIMER; ISOFLAVONE; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD BIOCHEMISTRY; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENDOTHELIAL MICROPARTICLE; FEMALE; FIBRINOLYSIS; HEMATOLOGICAL PARAMETERS; HUMAN; LIVER FUNCTION TEST; MEMBRANE MICROPARTICLE; MONOCYTE; OUTCOME ASSESSMENT; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; BLOOD; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NORMAL HUMAN; PROSPECTIVE STUDY; TAIWAN;

BIOMARKERS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CELL-DERIVED MICROPARTICLES; DOUBLE-BLIND METHOD; FEMALE; HEALTHY VOLUNTEERS; HUMANS; ISOFLAVONES; MIDDLE AGED; PHYTOESTROGENS; POSTMENOPAUSE; PROSPECTIVE STUDIES; TAIWAN;

EID: 84940439438     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2013.11.001     Document Type: Article

References (33)

1. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998, 280:605-613.
2. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
3. Xiao C.W. Health effects of soy protein and isoflavones in humans. J Nutr 2008, 138:1244S-1249S.
4. Tempfer C.B., Froese G., Heinze G., Bentz E.K., Hefler L.A., Huber J.C. Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med 2009, 122:939-946. e9.
5. Wuttke W., Jarry H., Seidlová-Wuttke D. Isoflavones-safe food additives or dangerous drugs?. Ageing Res Rev 2007, 6:150-188.
6. Alexandersen P., Toussaint A., Christiansen C., Devogelaer J.P., Roux C., Fechtenbaum J., et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001, 285:1482-1488.
7. Agnusdei D., Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int 1997, 61(Suppl. 1):S23-S27.
8. Soung do Y., Patade A., Khalil D.A., Lucas E.A., Devareddy L., Greaves K.A., et al. Soy protein supplementation does not cause lymphocytopenia in postmenopausal women. Nutrition J 2006, 5:12.
9. Pradhan A.D., Manson J.E., Rossouw J.E., Siscovick D.S., Mouton C.P., Rifai N., et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002, 288:980-987.
10. Rios D.R., Rodrigues E.T., Cardoso A.P., Montes M.B., Franceschini S.A., Toloi M.R. Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women. Nutrition 2008, 24:120-126.
11. Verheus M., van Gils C.H., Kreijkamp-Kaspers S., Kok L., Peeters P.H., Grobbee D.E., et al. Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008, 17:2632-2638.
12. Bitto A., Altavilla D., Bonaiuto A., Polito F., Minutoli L., Di Stefano V., et al. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. J Endocrinol 2009, 200:367-376.
13. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
14. Pilšáková L., Riečanský I., Jagla F. The physiological actions of isoflavone phytoestrogens. Physiol Res 2010, 59:651-664.
15. Enjeti A.K., Lincz L.F., Seldon M. Microparticles in health and disease. Semin Thromb Hemost 2008, 34:683-691.
16. Burnier L., Fontana P., Kwak B.R., Angelillo-Scherrer A. Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 2009, 101:439-451.
17. Leroyer A.S., Tedgui A., Boulanger C.M. Role of microparticles in atherothrombosis. J Intern Med 2008, 263:528-537.
18. Chironi G.N., Boulanger C.M., Simon A., Dignat-George F., Freyssinet J.M., Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009, 335:143-151.
19. Jayachandran M., Litwiller R.D., Owen W.G., Heit J.A., Behrenbeck T., Mulvagh S.L., et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 2008, 295:H931-H938.
20. Tai T.Y., Tsai K.S., Tu S.T., Wu J.S., Chang C.I., Chen C.L., et al. The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study. Osteoporosis Int 2012, 23:1571-1580.
21. Chirinos J.A., Zambrano J.P., Virani S.S., Jimenez J.J., Jy W., Ahn E., et al. Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men. Am J Cardiol 2005, 95:1258-1260.
22. Komesaroff P.A., Sudhir K. Estrogens and human cardiovascular physiology. Reprod Fertil Dev 2001, 13:261-272.
23. Brzezinski A., Danenberg H.D. Sex hormones, soy, and myocardial injury. Menopause 2008, 15:217-220.
24. Agouni A., Lagrue-Lak-Hal A.H., Ducluzeau P.H., Mostefai H.A., Draunet-Busson C., Leftheriotis G., et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008, 173:1210-1219.
25. Jayachandran M., Litwiller R.D., Owen W.G., Miller V.M. Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric 2009, 12:177-184.
26. Wang Y., Jones P.J., Ausman L.M., Lichtenstein A.H. Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. Atherosclerosis 2004, 173:269-275.
27. Dent S.B., Peterson C.T., Brace L.D., Swain J.H., Reddy M.B., Hanson K.B., et al. Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. J Nutr 2001, 131:2280-2287.
28. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., Winston M., et al. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113:1034-1044.
29. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., Winston M. Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the American heart association nutrition committee. Arterioscler Thromb Vasc Biol 2006, 26:1689-1692.
30. Pipe E.A., Gobert C.P., Capes S.E., Darlington G.A., Lampe J.W., Duncan A.M. Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B: apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr 2009, 139:1700-1706.
31. Rivas M., Garay R.P., Escanero J.F., Cia P., Cia P., Alda J.O. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 2002, 132:1900-1902.
32. Hodgson J.M., Puddey I.B., Beilin L.J., Mori T.A., Burke V., Croft K.D., et al. Effects of isoflavonoids on blood pressure in subjects with high-normal ambulatory blood pressure levels: a randomized controlled trial. Am J Hypertens 1999, 12:47-53.
33. Welty F.K., Lee K.S., Lew N.S., Zhou J.R. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 2007, 167:1060-1067.